Home LiteratureArticle Details
PMID: 2421936 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Cancer chemotherapy and pharmacology ·Vol. 17 ·No. 1 ·1986-00-00 ·Pages 1-10

Bosanquet AG

Abstract

The methods used to test drug stability are discussed in the light of two recent publications using biological assays. It is concluded that, as far as possible, stability-indicating assays should be used so that possible false results do not lead to erroneous conclusions. Many of the results of the stability studies with adriamycin were found to be at variance with each other, with a 20-fold difference in stability being reported in one case by different groups from virtually identical experiments. Definitive statements about adriamycin stability are therefore impossible, but it is clear that it is sensitive to light, adsorbs to membrane filters and containers (except polypropylene and siliconised glass), chelates metal ions and probably degrades rapidly in medium. Adriamycin's analogues may well have the same spectrum of sensitivity. Bleomycin, actinomycin D and neocarzinostatin were found to be stable for greater than or equal to 2 weeks at room temperature. All the other antitumour antibiotics investigated (except rubidazone) are stable for greater than or equal to 24 h at room temperature and longer at 5 degrees C. Almost all of them are sensitive to light and are most stable in neutral or slightly acid media, and many of them adsorb to membrane filters. They can probably all be stored frozen in solution.

MeSH Terms
Adsorption Anthraquinones Antibiotics, Antineoplastic/analysis Biological Assay Bleomycin Daunorubicin/analogs & derivatives Doxorubicin/analysis,radiation effects Drug Packaging Drug Stability Freezing Light Metals Methods Micropore Filters Mitoxantrone Solutions
Chemicals
Anthraquinones Antibiotics, Antineoplastic Metals Solutions Bleomycin Doxorubicin Mitoxantrone zorubicin Daunorubicin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Bosanquet A G
References (96)
96 references, click to expand
  1. Pharmacologic pitfalls in the human tumor clonogenic assay.
    Recent Results Cancer Res. 1984;94:184-90 PMID: 6494578
  2. Ultraviolet photoirradiation of daunomycin and DNA daunomycin complexes.
    Photochem Photobiol. 1981 Mar;33(3):297-303 PMID: 7255559
  3. Possible incompatibility of doxorubicin hydrochloride with aluminum.
    Am J Hosp Pharm. 1981 Sep;38(9):1276 PMID: 7282707
  4. Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study.
    Invest New Drugs. 1983;1(2):173-9 PMID: 6590531
  5. Stability of anthracycline antitumor agents in four infusion fluids.
    Am J Hosp Pharm. 1981 Apr;38(4):483-6 PMID: 6945043
  6. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Cancer Res. 1982 Oct;42(10):4026-31 PMID: 6179595
  7. Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin.
    J Clin Oncol. 1984 Apr;2(4):282-6 PMID: 6707716
  8. Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids.
    J Chromatogr. 1984 Mar 9;306:323-32 PMID: 6585367
  9. Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activity.
    Cancer Invest. 1984;2(6):449-58 PMID: 6509356
  10. Structure of the antitumor protein neocarzinostatin. Purification, amino acid composition, disulfide reduction, and isolation and composition of tryptic peptides.
    Arch Biochem Biophys. 1974 Oct;164(2):369-78 PMID: 4282218
  11. Stability of mitomycin admixtures.
    Am J Hosp Pharm. 1985 Aug;42(8):1750-4 PMID: 4036973
  12. Stability of injectable medications after reconstitution.
    Am J Hosp Pharm. 1976 Aug;33(8):767-91 PMID: 949061
  13. Quantitation of chemosensitivity in acute myelocytic leukaemia.
    Br J Cancer. 1983 Oct;48(4):559-67 PMID: 6578837
  14. Self-association of daunomycin.
    Biochemistry. 1982 Aug 17;21(17 ):3927-32 PMID: 7126523
  15. Photolytic destruction of adriamycin.
    J Pharm Pharmacol. 1981 Aug;33(8):556 PMID: 6115938
  16. Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies.
    Leuk Res. 1986;10(4):445-9 PMID: 2421109
  17. Chemosensitivity of human neoplasms with in vitro clone formation. Experience at the University of Southern California - Los Angeles County Medical Center.
    Cancer Chemother Pharmacol. 1981;6(3):245-51 PMID: 6274537
  18. Photolytic degradation of adriamycin.
    J Pharm Pharmacol. 1980 Dec;32(12):860-2 PMID: 6110755
  19. Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity.
    Cancer Chemother Pharmacol. 1983;11(1):8-15 PMID: 6883628
  20. Liquid chromatographic determination of mitomycin C in human plasma and urine.
    J Chromatogr. 1983 May 13;274:263-70 PMID: 6409914
  21. An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.
    Br J Cancer. 1983 Jun;47(6):781-9 PMID: 6190492
  22. Usefulness of the human tumor colony forming assay for new drug development.
    Recent Results Cancer Res. 1984;94:237-44 PMID: 6494584
  23. Bleomycin compatibility with selected intravenous medications.
    J Med. 1982;13(1-2):121-30 PMID: 6181179
  24. High-performance liquid chromatographic determination of components of bleomycin preparations.
    J Pharm Sci. 1981 Aug;70(8):878-80 PMID: 6171636
  25. Stability of refrigerated and frozen solutions of doxorubicin hydrochloride.
    Am J Hosp Pharm. 1979 Nov;36(11):1536-8 PMID: 517541
  26. Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone.
    Cancer Treat Rep. 1983 Nov;67(11):1019-22 PMID: 6688965
  27. In vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4'-O-tetrapyranyl-doxorubicin: correlations with clinical responses.
    J Clin Oncol. 1984 Nov;2(11):1215-22 PMID: 6593437
  28. Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.
    Br J Cancer. 1980 Apr;41(4):644-7 PMID: 6155927
  29. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.
    Cancer Res. 1983 Feb;43(2):749-57 PMID: 6184155
  30. Chemosensitivity tests by a miniclone technique.
    Med Oncol Tumor Pharmacother. 1984;1(1):19-23 PMID: 6242420
  31. Concomitant adsorption and stability of some anthracycline antibiotics.
    J Pharm Sci. 1982 Oct;71(10):1121-5 PMID: 6958860
  32. Stability of melphalan solutions during preparation and storage.
    J Pharm Sci. 1985 Mar;74(3):348-51 PMID: 4009450
  33. Photolability of bleomycin and its complexes.
    Cancer Lett. 1981 Aug;13(3):265-8 PMID: 6170427
  34. Prospective clinical trial of a human tumor cloning system.
    Cancer Res. 1983 Apr;43(4):1926-31 PMID: 6339044
  35. Experimental approaches to drug testing and clonogenic growth: results in multiple myeloma and acute myelogenous leukemia.
    Recent Results Cancer Res. 1984;94:93-101 PMID: 6593779
  36. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro.
    Cancer Res. 1983 Feb;43(2):517-20 PMID: 6184147
  37. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.
    Cancer Chemother Pharmacol. 1985;14(2):83-95 PMID: 3882257
  38. Effect of inline filtration on the potency of drugs administered intravenously.
    Am J Hosp Pharm. 1977 Oct;34(10):1071-4 PMID: 920741
  39. Avoiding common flaws in stability and compatibility studies of injectable drugs.
    Am J Hosp Pharm. 1983 Jul;40(7):1159-60 PMID: 6881152
  40. Structure of the antitumor protein neocarzinostatin. Amino acid sequence.
    Arch Biochem Biophys. 1974 Oct;164(2):379-85 PMID: 4282219
  41. Doxorubicin degradation: changes in activity compared by bacterial growth inhibition and free radical-dependent damage to deoxyribose.
    J Biol Stand. 1983 Oct;11(4):359-64 PMID: 6643513
  42. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.
    Proc Natl Acad Sci U S A. 1975 Mar;72(3):937-40 PMID: 48253
  43. Comparison of the properties of metabolites of CCNU.
    Biochem Pharmacol. 1977 Dec 15;26(24):2331-6 PMID: 145865
  44. Potential limitations of in vitro clonogenic drug sensitivity assays.
    Cancer Chemother Pharmacol. 1984;13(3):206-10 PMID: 6488440
  45. Storage of chemotherapy drugs for use in the human tumor stem cell assay.
    Int J Cell Cloning. 1984 Jan;2(1):2-8 PMID: 6707489
  46. Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.
    Br J Cancer. 1984 Mar;49(3):301-6 PMID: 6704304
  47. Self-association of doxorubicin and related compounds in aqueous solution.
    J Pharm Sci. 1984 Jun;73(6):766-70 PMID: 6588195
  48. Letter: Preparing multiple doses of bleomycin sulfate.
    Am J Hosp Pharm. 1974 Jul;31(7):631 PMID: 4136976
  49. Interaction of human serum albumin with anticancer agents in vitro.
    Br J Cancer. 1980 Apr;41(4):602-8 PMID: 7190020
  50. Radioimmunoassay of bleomycin in plasma and urine.
    Br J Cancer. 1977 Jun;35(6):822-7 PMID: 68783
  51. Effect of light and oxygen on neocarzinostatin stability and DNA-cleaving activity.
    J Biol Chem. 1978 Jul 25;253(14):4830-2 PMID: 149790
  52. [Studies on the stability of antitumor protein, neocarzinostatin. II. Stability of injection of neocarzinostatin (author's transl)].
    Jpn J Antibiot. 1974 Dec;27(6):715-24 PMID: 4282495
  53. In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
    Br J Cancer. 1982 Dec;46(6):870-9 PMID: 6891260
  54. Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone.
    J Chromatogr. 1982 Dec 10;233:235-47 PMID: 7161336
  55. Binding of selected drugs to a "treated" inline filter.
    Am J Hosp Pharm. 1983 Aug;40(8):1323-8 PMID: 6225336
  56. In vitro chemosensitivity of human bladder cancer.
    Cancer. 1983 Apr 15;51(8):1490-6 PMID: 6186358
  57. Application of a human tumor colony-forming assay to new drug screening.
    Cancer Res. 1985 May;45(5):2145-53 PMID: 3986767
  58. Physicochemical characteristics of ferric adriamycin complexes.
    Cancer Chemother Pharmacol. 1984;12 (1):5-9 PMID: 6690074
  59. High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics.
    Life Sci. 1981 Jul 27;29(4):361-9 PMID: 7278493
  60. The anticancer agent adriamycin can be actively cytotoxic without entering cells.
    Science. 1982 Jul 16;217(4556):248-50 PMID: 7089561
  61. Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line.
    Gynecol Oncol. 1982 Oct;14(2):243-61 PMID: 7129221
  62. Direct in vitro photoaffinity labeling of DNA with daunorubicin, adriamycin, and rubidazone.
    Biochim Biophys Acta. 1979 Nov 22;565(1):13-21 PMID: 508759
  63. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    Cancer Res. 1980 Feb;40(2):387-94 PMID: 7356521
  64. Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma.
    Br J Cancer. 1983 Feb;47(2):205-14 PMID: 6297528
  65. Doxorubicin hydrochloride-aluminum interaction.
    Am J Hosp Pharm. 1983 Feb;40(2):214 PMID: 6829575
  66. Chemopotentiation of CCNU metabolites by misonidazole.
    Br J Cancer. 1985 May;51(5):733-5 PMID: 3994915
  67. DNA cleavages of bleomycin-transition metal complexes induced by reductant, hydrogen peroxide, and ultraviolet light: characteristics and biological implication.
    Nucleic Acids Symp Ser. 1984;(15):161-4 PMID: 6084237
  68. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
    N Engl J Med. 1978 Jun 15;298(24):1321-7 PMID: 77475
  69. Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)-amino)9,10-anthracenedio ne dihydrochloride (NSC 301739) in plasma. Application of temperature control to provide selectivity in paired-ion high-performance liquid chromatography.
    J Chromatogr. 1981 Feb 13;222(2):225-40 PMID: 7251740
  70. Photoactivity of bleomycin.
    Biomed Pharmacother. 1983;37(4):191-3 PMID: 6198004
  71. Phase II study of carminomycin in a human tumor cloning assay.
    Invest New Drugs. 1984;2(3):267-70 PMID: 6511232
  72. Stability and compatibility of antitumor agents in glass and plastic containers.
    Am J Hosp Pharm. 1981 Dec;38(12):1914-8 PMID: 7325172
  73. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.
    Am J Med. 1981 May;70(5):1027-41 PMID: 7234870
  74. Quantitative determination of adriamycin and daunorubicin-handling of blood and plasma samples.
    Acta Pharm Suec. 1981;18(4):215-20 PMID: 7315366
  75. Development of an antibody to actinomycin D and its application for the detection of serum levels by radioimmunoassay.
    Cancer Res. 1982 Mar;42(3):1184-7 PMID: 6174214
  76. Radiobiological techniques applied to environmental problems.
    Radiat Res. 1978 Dec;76(3):459-70 PMID: 734053
  77. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells.
    J Natl Cancer Inst. 1976 Nov;57(5):1063-7 PMID: 1003542
  78. Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote.
    Invest New Drugs. 1984;2(4):351-7 PMID: 6096286
  79. Effect of step-down heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum.
    Cancer Res. 1984 May;44(5):1823-6 PMID: 6201263
  80. Physiochemical properties and stability of aclacinomycin A hydrochloride.
    Jpn J Antibiot. 1980 May;33(5):618-22 PMID: 6933235
  81. Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution.
    J Pharm Sci. 1978 Jun;67(6):782-5 PMID: 660455
  82. Photoreactivity of bleomycin and its implications.
    Bull Cancer. 1983;70(5):372-80 PMID: 6199058
  83. Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay.
    Cancer Chemother Pharmacol. 1984;12(3):142-5 PMID: 6705131
  84. ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS.
    Biochim Biophys Acta. 1965 May 11;103:25-49 PMID: 14336441
  85. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity.
    Cancer Res. 1983 Jan;43(1):258-64 PMID: 6571706
  86. Cytotoxic efficacy of reconstituted and stored antitumor agents.
    Cancer Res. 1985 Apr;45(4):1511-5 PMID: 3978618
  87. Mechanism of bleomycin action: in vitro studies.
    Life Sci. 1981 Feb 16;28(7):715-27 PMID: 6164898
  88. Effect of inline filtration on the potency of low-dose drugs.
    Am J Hosp Pharm. 1980 Jul;37(7):935-41 PMID: 7395887
  89. 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
    Cancer Treat Rev. 1983 Mar;10(1):1-22 PMID: 6342772
  90. Direct cloning of human breast cancer in soft agar culture.
    Cancer. 1982 Oct 1;50(7):1315-21 PMID: 7049348
  91. [Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin (author's transl)].
    Jpn J Antibiot. 1974 Dec;27(6):707-14 PMID: 4282494
  92. Correlation of cellular tritiated thymidine incorporation with soft agar clonogenicity in chemosensitivity testing of human neuroblastoma cells.
    Cancer Treat Rep. 1983 Feb;67(2):163-8 PMID: 6825124
  93. Mithramycin for hypercalcemia of malignant disease.
    Calif Med. 1971 Oct;115(4):1-4 PMID: 4255688
  94. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
    Cancer Res. 1984 Mar;44(3):923-8 PMID: 6692414
  95. In vitro determination of tumour chemosensitivity in haematological malignancies.
    Hematol Oncol. 1985 Jan-Mar;3(1):1-10 PMID: 2580768
  96. Phase I trial of an implanted battery-powered, programmable drug delivery system for continuous doxorubicin administration.
    J Clin Oncol. 1985 Mar;3(3):407-14 PMID: 3973652
Article Info
Journal
Cancer chemotherapy and pharmacology
Abbr.
Cancer Chemother Pharmacol
ISSN
0344-5704
Published
1986-00-00
Pages
1-10
Language
English
Region
Germany
NLM ID
7806519
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com